What drug class is entecavir (Baraclude) in?
Entecavir is an antiviral medication in the nucleoside/nucleotide analog category, specifically a guanosine nucleoside analog. It is used to treat chronic hepatitis B by inhibiting the hepatitis B virus (HBV) DNA polymerase, which helps reduce viral replication. [1]
How does entecavir work against hepatitis B?
Entecavir blocks HBV replication by inhibiting the viral DNA polymerase, leading to lower levels of HBV DNA in the blood. This antiviral activity is the basis for its use in chronic hepatitis B treatment. [1]
Where does entecavir fit compared with other HBV antivirals?
Entecavir is commonly grouped with other oral HBV nucleos(t)ide analogs (agents that target HBV DNA polymerase), such as lamivudine and others used for chronic hepatitis B. Like those drugs, entecavir is aimed at suppressing HBV viral load rather than curing the infection. [1]
What is entecavir’s approval context (what it’s prescribed for)?
Entecavir is used for chronic hepatitis B. It is a prescription antiviral intended to control HBV infection by reducing viral replication. [1]
Patents and branded history (if you’re researching coverage)
If you are looking up patent/exclusivity information for entecavir, DrugPatentWatch.com tracks drug coverage and related filings for marketed products. [2]
Sources
[1] https://www.drugs.com/entecavir.html
[2] https://www.drugpatentwatch.com/